Brown Adipose TissueTACTICAL-IINCT02964442
Brown Adipose Tissue Activation and Energy Expenditure by Capsinoids Stimulation With Trimodality Imaging Using 18-FDG-PET, Fat Fraction MRI and Infrared Thermography
A study testing Capsinoids and Cold Stimulus in people with Brown Adipose Tissue, run by Singapore Institute of Food and Biotechnology Innovation at 1 site in Singapore.
Trial summary
Brown adipose tissue (BAT) thermogenesis can be assessed by IR thermography, the accompanying increase metabolic rate can be measured by whole body calorimetry and BAT volume can be precisely measured by MRI. Read more about this study
- Who is it for?
- Ages 21 to 40 yearsHealthy volunteers can take part
- Conditions the study is for
- Brown Adipose Tissue
- What is being tested?
- Capsinoids and Cold Stimulus
- Type of treatment
- Pill or oral medicine
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- 1 siteSingapore
- Study dates
- 23 Oct 2015to 24 Oct 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 21 to 40 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Overtly healthy with no past history of chronic illnesses
- Aged 21-40 years old Male and female gender
- BMI from 18.5 to 29.9 kg/m2 inclusive
- No prior history of thyroid disease.
- Euthyroid biochemically with FT4 and TSH in the normal ranges
Who cannot join
- Recent changes in weight of >5% over the past 6 months.
- Attempts to lose weight over the past 6 months.
- Significant changes in diet over the past 6 months.
- Any use of weight reducing drugs in the past 6 months.
- Previous weight reducing surgery.
- Any use of investigational drugs in the past 6 months.
Show all 17Show fewer
- Subclinical thyroid dysfunction based on thyroid function test.
- Chronic illnesses such as diabetes mellitus or cancer.
- You have a known history of thyroid, liver or kidney disease.
- Use of any prescription medication that cannot be safely discontinued within 14 days prior to study entry.
- Female subjects who are pregnant.
- Oral medications affecting brown fat activity (eg. alpha agonists or blockers, beta agonists or blockers, sympatholytic agents) which the researchers will clarify with you.
- Chronic topical ointment with menthol or capsaicin or use of nasal decongestants.
- History of surgery with metallic clips, staples or stents.
- Presence of cardiac pacemaker or other foreign body in any part of the body.
- History of claustrophobia particularly in a MRI scanner.
- Had a PET scan done within the past 4 months.
Trial locations and contacts
1 site in 1 country.
About this study
Brown adipose tissue (BAT) thermogenesis can be assessed by IR thermography, the accompanying increase metabolic rate can be measured by whole body calorimetry and BAT volume can be precisely measured by MRI. The aim of the study is to validate IRT for BAT thermogenesis against the present gold standard 18-FDG-PET scan, quantify BAT volume by fat fraction MRI and measure the accompanying increase in BMR by whole body calorimetry among healthy euthyroid subjects.
Read the detailed description
It is now known that human adults do possess viable brown fat in quantities that may be critical for maintenance of a normal basal metabolic rate (BMR) and body weight, dispelling the myth that BAT is only present during infancy for thermoregulation. There are data suggesting that obesity is associated with insufficient BAT. So far the only known and arguably 'gold standard' methodology of BAT imaging in humans is 18-FDG-PET. Yet 18-FDG-PET imaging has significant limitations, given its restricted spatial resolution and its non-trivial level of ionizing radiation (2.8 mSv). The International Commission for Radiological Protection recommends that the radiation exposure for the general public should not exceed 1mSv/year and 1.5 mSv/year from background radiation. In addition, 18-FDG-PET depends on glucose uptake by BAT that does not directly measure its key metabolic activity, namely fatty acid oxidation. Finally, PET scans are very costly. This makes the present gold standard far from ideal as a research tool for investigating BAT physiology. Thus the first objective of this project is to develop an alternative activated BAT imaging method that is not based on ionizing radiation. We are interested in advancing infrared (IR) thermography as a method to assess BAT activity by developing a novel image processing algorithms for IR thermography. Much extant literature describes the use of "average temperature" instead of IR heat flux using the physical principles of radiative heat transfer and thermodynamics to quantify heat from BAT. Also,IR digital still-shots were mostly employed in the past whereas none have reported the analysis of IR flux using a video sequence which more accurately integrates time-varying heat energy output. Without precision in capturing and processing the rich IR data, the value of IR thermography as a tool for BAT research is limited. It is thus crucial to convert the IR images into a readout that reflects energy output. We will thus develop, validate and apply automatic IR image processing with computer software that can efficiently calculate BAT activation. In this proposal we will also improve and validate anatomical fat fraction MRI as a tool for evaluating BAT volumes based on the higher water content in BAT compared with that in WAT. Fat fraction imaging by MRI has been proposed but no proper validation has been done due to the difficulty in matching PET and MRI data on BAT. Instead of using pharmacologic agents (e.g. beta 3-adrenergic receptor agonists such as mirabegron) that can be administered to activate BAT instead of cold stimulus, we will employ capsiate (i.e. capsinoids - non-spicy analogues of capsaicin in peppers and chilies) that have been proven to effectively stimulate BAT in thermoneutral conditions as confirmed by PET scans. We have conducted a preliminary study approved by the DSRB that showed the effectiveness of capsinoids in stimulating BAT. There are publications documenting the use of MRI in distinguishing BAT from WAT, each with their advantages and disadvantages. In this present study, we will perform a proof-of-concept study by simultaneous acquisition of MRI and 18-FDG-PET in a dual-modality fusion MRI-PET scanner available at the Clinical Imaging Research Centre (CIRC) to image BAT in humans, and correlate this with IR thermography of the cervical and supraclavicular regions (SCR) and with metabolic rate accurately measured in a whole body calorimeter. Whole body calorimetry is the real gold standard to assess BAT activity by measuring nonshivering thermogenesis. IR has so far been validated against 18-FDG-PET in mice and rodents, but equivalent validation in humans has not been published. If IR thermography is shown to be equivalent or superior to 18-FDG-PET imaging, it will set a new gold standard in BAT imaging which will be a boon for study of BAT biology in humans.
- Conditions
- Brown Adipose Tissue
- Being tested
- Capsinoids, Cold Stimulus
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
CapsinoidsOther
12 mg of Gel capsules
Cold StimulusOther
Cooling vest maintain at 14 degree Celsius
| Study group | Role | What they receive |
|---|---|---|
| Capsinoids | Experimental | 8 gel capsules equivalent to 12mg Receives: Other: Capsinoids |
| Cooling Vest | Experimental | Using Cooling vest (at approxiamately14 degrees Celsius) to cool the body. Receives: Other: Cold Stimulus |
What is being measured
The primary outcome is the main question the study is designed to answer.
Brown adipose tissue activation detection by Imaging using 18-FDG-PET/ MRI.
Measured: post consumption of capsinoids capsules for 2 hours
Energy Expenditure using Whole Body Calorimeter.
Measured: post consumption of capsinoids capsules for 2 hours
Brown adipose tissue activation detection by Imaging using Infrared Thermography.
Measured: post consumption of capsinoids capsules for 2 hours
Secondary outcomes (3)
Brown adipose tissue activation detection by Imaging using 18-FDG-PET/ MRI.
Measured: post cold stimulus up to 2 hours
Energy Expenditure using Whole Body Calorimeter.
Measured: To measure cold stimulus for 2 hours
Brown adipose tissue activation detection by Imaging using Infrared Thermography.
Measured: post cold stimulus up to 2 hours
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Nov 2016 (estimated)
- Study start23 Oct 2015
- Primary completion24 Oct 2023
- Study completion24 Oct 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for Brown Adipose TissueStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Non-randomised
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 30 participants (actual)
Sponsor and investigators
- Lead sponsor
- Singapore Institute of Food and Biotechnology Innovation
- Sponsor type
- Other government
- Collaborators
- Institute of Bioengineering and Bioimaging (IBB)
- Responsible party
- Principal investigator, Melvin Leow, Singapore Institute of Food and Biotechnology Innovation
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02964442
- Sponsor's protocol ID
- 2015/00715
- Other IDs
- 2015
- Acronym
- TACTICAL-II
- Status last verified
- May 2024
- First submitted
- 4 Nov 2016
- Last updated
- 10 May 2024
- Results posted
- No
- Data monitoring committee
- No
- Individual data sharing
- No
Publications
Sun L, Yan J, Goh HJ, Govindharajulu P, Verma S, Michael N, Sadananthan SA, Henry CJ, Velan SS, Leow MK. Fibroblast Growth Factor-21, Leptin, and Adiponectin Responses to Acute Cold-Induced Brown Adipose Tissue Activation. J Clin Endocrinol Metab. 2020 Mar 1;105(3):e520-31. doi: 10.1210/clinem/dgaa005.
PubMed 31912874Sun L, Verma S, Michael N, Chan SP, Yan J, Sadananthan SA, Camps SG, Goh HJ, Govindharajulu P, Totman J, Townsend D, Goh JP, Sun L, Boehm BO, Lim SC, Sze SK, Henry CJ, Hu HH, Velan SS, Leow MK. Brown Adipose Tissue: Multimodality Evaluation by PET, MRI, Infrared Thermography, and Whole-Body Calorimetry (TACTICAL-II). Obesity (Silver Spring). 2019 Sep;27(9):1434-1442. doi: 10.1002/oby.22560. Epub 2019 Jul 13.
PubMed 31301122Sun L, Camps SG, Goh HJ, Govindharajulu P, Schaefferkoetter JD, Townsend DW, Verma SK, Velan SS, Sun L, Sze SK, Lim SC, Boehm BO, Henry CJ, Leow MK. Capsinoids activate brown adipose tissue (BAT) with increased energy expenditure associated with subthreshold 18-fluorine fluorodeoxyglucose uptake in BAT-positive humans confirmed by positron emission tomography scan. Am J Clin Nutr. 2018 Jan 1;107(1):62-70. doi: 10.1093/ajcn/nqx025.
PubMed 29381803
Study at a glance
From the registry record, last updated by the sponsor on 10 May 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Brown Adipose Tissue Activation and Energy Expenditure by Capsinoids Stimulation With Trimodality Imaging Using 18-FDG-PET, Fat Fraction MRI and Infrared Thermography
- ClinicalTrials.gov ID
- NCT02964442
- Acronym / sponsor ID
- TACTICAL-II / 2015/00715
- Conditions
- Brown Adipose Tissue
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 30 participants (actual)
- Lead sponsor
- Singapore Institute of Food and Biotechnology InnovationOther government
- Collaborators
- Institute of Bioengineering and Bioimaging (IBB)
- Study start
- 23 Oct 2015 (actual)
- Primary completion
- 24 Oct 2023 (actual)
- Study completion
- 24 Oct 2023 (actual)
- First posted
- 16 Nov 2016 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Brown adipose tissue (BAT) thermogenesis can be assessed by IR thermography, the accompanying increase metabolic rate can be measured by whole body calorimetry and BAT volume can be precisely measured by MRI. The aim of the study is to validate IRT for BAT thermogenesis against the present gold standard 18-FDG-PET scan, quantify BAT volume by fat fraction MRI and measure the accompanying increase in BMR by whole body calorimetry among healthy euthyroid subjects.
Detailed description
It is now known that human adults do possess viable brown fat in quantities that may be critical for maintenance of a normal basal metabolic rate (BMR) and body weight, dispelling the myth that BAT is only present during infancy for thermoregulation. There are data suggesting that obesity is associated with insufficient BAT. So far the only known and arguably 'gold standard' methodology of BAT imaging in humans is 18-FDG-PET. Yet 18-FDG-PET imaging has significant limitations, given its restricted spatial resolution and its non-trivial level of ionizing radiation (2.8 mSv). The International Commission for Radiological Protection recommends that the radiation exposure for the general public should not exceed 1mSv/year and 1.5 mSv/year from background radiation. In addition, 18-FDG-PET depends on glucose uptake by BAT that does not directly measure its key metabolic activity, namely fatty acid oxidation. Finally, PET scans are very costly. This makes the present gold standard far from ideal as a research tool for investigating BAT physiology. Thus the first objective of this project is to develop an alternative activated BAT imaging method that is not based on ionizing radiation. We are interested in advancing infrared (IR) thermography as a method to assess BAT activity by developing a novel image processing algorithms for IR thermography. Much extant literature describes the use of "average temperature" instead of IR heat flux using the physical principles of radiative heat transfer and thermodynamics to quantify heat from BAT. Also,IR digital still-shots were mostly employed in the past whereas none have reported the analysis of IR flux using a video sequence which more accurately integrates time-varying heat energy output. Without precision in capturing and processing the rich IR data, the value of IR thermography as a tool for BAT research is limited. It is thus crucial to convert the IR images into a readout that reflects energy output. We will thus develop, validate and apply automatic IR image processing with computer software that can efficiently calculate BAT activation. In this proposal we will also improve and validate anatomical fat fraction MRI as a tool for evaluating BAT volumes based on the higher water content in BAT compared with that in WAT. Fat fraction imaging by MRI has been proposed but no proper validation has been done due to the difficulty in matching PET and MRI data on BAT. Instead of using pharmacologic agents (e.g. beta 3-adrenergic receptor agonists such as mirabegron) that can be administered to activate BAT instead of cold stimulus, we will employ capsiate (i.e. capsinoids - non-spicy analogues of capsaicin in peppers and chilies) that have been proven to effectively stimulate BAT in thermoneutral conditions as confirmed by PET scans. We have conducted a preliminary study approved by the DSRB that showed the effectiveness of capsinoids in stimulating BAT. There are publications documenting the use of MRI in distinguishing BAT from WAT, each with their advantages and disadvantages. In this present study, we will perform a proof-of-concept study by simultaneous acquisition of MRI and 18-FDG-PET in a dual-modality fusion MRI-PET scanner available at the Clinical Imaging Research Centre (CIRC) to image BAT in humans, and correlate this with IR thermography of the cervical and supraclavicular regions (SCR) and with metabolic rate accurately measured in a whole body calorimeter. Whole body calorimetry is the real gold standard to assess BAT activity by measuring nonshivering thermogenesis. IR has so far been validated against 18-FDG-PET in mice and rodents, but equivalent validation in humans has not been published. If IR thermography is shown to be equivalent or superior to 18-FDG-PET imaging, it will set a new gold standard in BAT imaging which will be a boon for study of BAT biology in humans.
Study design
- Primary purpose
- Other
- Allocation
- Non-randomised
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Capsinoids | Experimental | Other: Capsinoids8 gel capsules equivalent to 12mg |
| Cooling Vest | Experimental | Other: Cold StimulusUsing Cooling vest (at approxiamately14 degrees Celsius) to cool the body. |
Who may qualify
- Ages
- 21 to 40 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (5 listed)
- Overtly healthy with no past history of chronic illnesses
- Aged 21-40 years old Male and female gender
- BMI from 18.5 to 29.9 kg/m2 inclusive
- No prior history of thyroid disease.
- Euthyroid biochemically with FT4 and TSH in the normal ranges
Key exclusion criteria (17 listed)
- Recent changes in weight of >5% over the past 6 months.
- Attempts to lose weight over the past 6 months.
- Significant changes in diet over the past 6 months.
- Any use of weight reducing drugs in the past 6 months.
- Previous weight reducing surgery.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Capsinoids12 mg of Gel capsules | Other | Capsinoids |
| Cold StimulusCooling vest maintain at 14 degree Celsius | Other | Cooling Vest |
Primary outcome
Brown adipose tissue activation detection by Imaging using 18-FDG-PET/ MRI.
Time frame: post consumption of capsinoids capsules for 2 hours
Energy Expenditure using Whole Body Calorimeter.
Time frame: post consumption of capsinoids capsules for 2 hours
Brown adipose tissue activation detection by Imaging using Infrared Thermography.
Time frame: post consumption of capsinoids capsules for 2 hours
3 secondary outcomes
Brown adipose tissue activation detection by Imaging using 18-FDG-PET/ MRI.
Time frame: post cold stimulus up to 2 hours
Energy Expenditure using Whole Body Calorimeter.
Time frame: To measure cold stimulus for 2 hours
Brown adipose tissue activation detection by Imaging using Infrared Thermography.
Time frame: post cold stimulus up to 2 hours
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 May 2024.
- Derived from this study: PubMed 31912874Sun L, Yan J, Goh HJ, Govindharajulu P, Verma S, Michael N, Sadananthan SA, Henry CJ, Velan SS, Leow MK. Fibroblast Growth Factor-21, Leptin, and Adiponectin Responses to Acute Cold-Induced Brown Adipose Tissue Activation. J Clin Endocrinol Metab. 2020 Mar 1;105(3):e520-31. doi: 10.1210/clinem/dgaa005.
- Derived from this study: PubMed 31301122Sun L, Verma S, Michael N, Chan SP, Yan J, Sadananthan SA, Camps SG, Goh HJ, Govindharajulu P, Totman J, Townsend D, Goh JP, Sun L, Boehm BO, Lim SC, Sze SK, Henry CJ, Hu HH, Velan SS, Leow MK. Brown Adipose Tissue: Multimodality Evaluation by PET, MRI, Infrared Thermography, and Whole-Body Calorimetry (TACTICAL-II). Obesity (Silver Spring). 2019 Sep;27(9):1434-1442. doi: 10.1002/oby.22560. Epub 2019 Jul 13.
- Derived from this study: PubMed 29381803Sun L, Camps SG, Goh HJ, Govindharajulu P, Schaefferkoetter JD, Townsend DW, Verma SK, Velan SS, Sun L, Sze SK, Lim SC, Boehm BO, Henry CJ, Leow MK. Capsinoids activate brown adipose tissue (BAT) with increased energy expenditure associated with subthreshold 18-fluorine fluorodeoxyglucose uptake in BAT-positive humans confirmed by positron emission tomography scan. Am J Clin Nutr. 2018 Jan 1;107(1):62-70. doi: 10.1093/ajcn/nqx025.
- Individual participant dataSharing planned: No
Related trials for Brown Adipose Tissue
RecruitingObservational study
A Multi-modal Cohort Study of Brown Adipose Tissue Based on Paired Comparisons at Room Temperature and After Cold Exposure
Brown Adipose Tissue, Human
RecruitingPhase 4
Mechanisms of Weight Loss: Tirzepatide vs Semaglutide
Obesity (Disorder)
Recruiting
Brown Adipose Tissue Modulation in Polycystic Ovary Syndrome Using Infrared Thermography
Polycystic Ovary Syndrome (PCOS)
Not yet recruiting
Exercise and Prolonged Fasting to Improve Brown Adipose Tissue Function in Postmenopausal Women
Cardiometabolic Diseases, Postmenopause
RecruitingObservational study
Molecular, Cellular, and Genetic Characterization of Human Adipose Tissue and Its Role in Metabolism
Brown Adipose Tissue (BAT) Physiology, Phenotyping
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Capsinoids and Cold Stimulus in people with Brown Adipose Tissue, run by Singapore Institute of Food and Biotechnology Innovation at 1 site in Singapore.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 17 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 10 May 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Singapore. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Brown adipose tissue activation detection by Imaging using 18-FDG-PET/ MRI. (time frame: post consumption of capsinoids capsules for 2 hours). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02964442, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 May 2024.